Mechanisms of Stimulating Innate Immunity
刺激先天免疫的机制
基本信息
- 批准号:9115045
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibiotic TherapyAntibioticsAntimicrobial ResistanceApplications GrantsAutoimmune DiseasesBacterial InfectionsBiologicalBiological AssayBiological ModelsBiologyCaenorhabditis elegansCellular StructuresChemicalsCommunicable DiseasesDataDevelopmentDiseaseDrosophila genusEnterococcus faecalisEnterococcus faeciumEnvironmentEpithelial CellsEquipmentEscherichia coliFellowshipFoodGene ExpressionGeneral HospitalsGenesGeneticGenetic EpistasisGenetic ProcessesGoalsGrantHealthHumanHyperthermiaHypoxiaImmuneImmune responseImmune systemInfectionInflammationInflammatoryIntestinesInvertebratesLaboratoriesLiquid substanceMalignant NeoplasmsMammalsManuscriptsMassachusettsMediatingMentorsMethodsMicrobeMolecularMorbidity - disease rateMusNatural ImmunityNematodaOxidative StressPathway interactionsPersonal SatisfactionPlayPositioning AttributePreparationProbioticsProcessPropertyPseudomonasPseudomonas aeruginosaPublicationsReporterReportingResistanceRoleScientistSignal TransductionSourceSpecificityStressSymptomsTestingTherapeuticTrainingVancomycin ResistanceVertebratesadaptive immunityantimicrobialbasebiological adaptation to stresscareerchemical geneticsimmune activationinsightinterestkillingsknock-downmacrophagemedical schoolsmicrobialmicrobiomemitogen-activated protein kinase p38mortalitynovelpathogenpreventprotective effectresponseskillssmall molecule
项目摘要
DESCRIPTION (provided by applicant): The spread of antimicrobial resistance is quickly outstripping the development of novel antibiotics, creating a looming danger for human health and well-being. One means for avoiding this health crisis is the identification of mechanisms to stimulate the innate immune system of the host instead, enabling increased microbial clearance. In addition, host stimulation is likely to prove a more difficult target for the adaptive genetic processes of microbes, as it unbalances the host-pathogen interaction, rather than simply killing the pathogen or preventing its replication. For this grant, I will utilize a novel C. elegans liqui infection assay that I have developed and characterized. C. elegans possesses evolutionarily conserved innate immune pathways similar to those of humans. In Specific Aim 1, the mechanisms used by small molecules with immunostimulatory properties identified in my earlier efforts will be characterized. I will also determine whether this activity is conserved by testing or activation and polarization of murine macrophages. In this fashion, insights into mechanisms of immune activation in vertebrate model organisms will be gained, potentially identifying novel targets for human therapeutics. For Specific Aim 2, I will investigate a mechanism of immune stimulation induced by rearing worms on a specific bacterial food source. The stimulatory mechanisms uncovered may yield new insights into intestinal infections, autoimmune disorders, and intestinal inflammatory conditions. Portions of each aim will be undertaken while I complete my mentored postdoctoral fellowship, but both will be completed once I have an independent position. My current environment, at both the institutional and the laboratory levels, is outstanding. Dr. Fred Ausubel, one of my mentors, pioneered the study of C. elegans innate immunity. Dr. Ruvkun is a leader in the field of stress responses in C. elegans. I've had the opportunity to be co-mentored by both of these exemplary scientists, maximizing my training. In addition, the facilities, equipment, and scientific environment at Massachusetts General Hospital and Harvard Medical School, where I am jointly appointed, are amongst the best in the world. I am interested in developing increased understanding about the integrated the responses to abiotic (e.g., hyperthermia, hypoxia, oxidative stress) and biological stresses (including infection, inflammation, and cancer). Toward that end, my career has focused on assembling the skills necessary to probe these pathways. My immediate career plans include publication of ongoing analysis regarding the host aspect of the liquid killing assay that I have developed. This will more solidly ground the findings that will be acquired during this grant. The next important step in that progression involves a transition to an independent position and acquiring preliminary data for an R01 grant application, which will be greatly facilitated by the acquisition
of this grant.
描述(由申请人提供):抗菌素耐药性的蔓延速度很快超过了新型抗生素的发展速度,对人类健康和福祉造成了迫在眉睫的危险。避免这种健康危机的一种方法是确定刺激宿主先天免疫系统的机制,从而增加微生物清除率。此外,宿主刺激可能被证明是微生物适应性遗传过程的更困难的目标,因为它不平衡宿主与病原体的相互作用,而不是简单地杀死病原体或阻止其复制。对于这笔资助,我将利用我开发和表征的新型线虫液体感染测定法。线虫拥有与人类相似的进化保守的先天免疫途径。在具体目标 1 中,将描述我在早期工作中发现的具有免疫刺激特性的小分子所使用的机制。我还将通过测试或小鼠巨噬细胞的激活和极化来确定这种活性是否保守。通过这种方式,我们将深入了解脊椎动物模型生物体的免疫激活机制,从而有可能确定人类治疗的新靶点。对于具体目标 2,我将研究在特定细菌食物源上饲养蠕虫所诱导的免疫刺激机制。所揭示的刺激机制可能会给肠道感染、自身免疫性疾病和肠道炎症带来新的见解。每个目标的部分内容将在我完成指导的博士后奖学金期间实现,但一旦我拥有独立职位,这两个目标都将完成。 我目前的环境,无论是机构还是实验室层面,都是非常出色的。 Fred Ausubel 博士是我的导师之一,他开创了线虫先天免疫研究的先河。 Ruvkun 博士是线虫应激反应领域的领导者。我有机会得到这两位模范科学家的共同指导,最大限度地提高了我的训练水平。此外,我所任职的麻省总医院和哈佛医学院的设施、设备和科研环境都是世界上最好的。 我感兴趣的是加深对非生物(例如高温、缺氧、氧化应激)和生物应激(包括感染、炎症和癌症)的综合反应的理解。为此,我的职业生涯专注于整合探索这些途径所需的技能。我近期的职业计划包括发表有关我开发的液体杀灭测定的宿主方面的持续分析。这将为本次拨款期间获得的发现提供更坚实的基础。该进展的下一个重要步骤涉及过渡到独立职位并获取 R01 拨款申请的初步数据,这将通过收购极大地促进
这笔补助金。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PqsA Promotes Pyoverdine Production via Biofilm Formation.
- DOI:10.3390/pathogens7010003
- 发表时间:2017-12-25
- 期刊:
- 影响因子:0
- 作者:Kang D;Turner KE;Kirienko NV
- 通讯作者:Kirienko NV
High-Throughput Genetic Screen Reveals that Early Attachment and Biofilm Formation Are Necessary for Full Pyoverdine Production by Pseudomonas aeruginosa.
- DOI:10.3389/fmicb.2017.01707
- 发表时间:2017
- 期刊:
- 影响因子:5.2
- 作者:Kang D;Kirienko NV
- 通讯作者:Kirienko NV
Identification and validation of a novel anti-virulent that binds to pyoverdine and inhibits its function.
- DOI:10.1080/21505594.2020.1819144
- 发表时间:2020-12
- 期刊:
- 影响因子:5.2
- 作者:Wang X;Kleerekoper Q;Revtovich AV;Kang D;Kirienko NV
- 通讯作者:Kirienko NV
Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa.
- DOI:10.1007/s12275-018-8114-3
- 发表时间:2018-07
- 期刊:
- 影响因子:0
- 作者:Kang D;Kirienko NV
- 通讯作者:Kirienko NV
A conserved mitochondrial surveillance pathway is required for defense against Pseudomonas aeruginosa.
防御铜绿假单胞菌需要保守的线粒体监视途径。
- DOI:10.1371/journal.pgen.1006876
- 发表时间:2017
- 期刊:
- 影响因子:4.5
- 作者:Tjahjono,Elissa;Kirienko,NataliaV
- 通讯作者:Kirienko,NataliaV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Natasha Kirienko其他文献
Natasha Kirienko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Natasha Kirienko', 18)}}的其他基金
Coordinated Regulation of Mitochondrial Surveillance
线粒体监视的协调调节
- 批准号:
10392664 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
Coordinated Regulation of Mitochondrial Surveillance
线粒体监视的协调调节
- 批准号:
10475354 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
Coordinated Regulation of Mitochondrial Surveillance
线粒体监视的协调调节
- 批准号:
10240482 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
Coordinated Regulation of Mitochondrial Surveillance
线粒体监视的协调调节
- 批准号:
9769065 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
Utilizing a novel liquid-killing assay to gain insight into C. elegans immunity
利用新型液体杀灭测定来深入了解秀丽隐杆线虫的免疫力
- 批准号:
8311400 - 财政年份:2012
- 资助金额:
$ 10.8万 - 项目类别:
Utilizing a novel liquid-killing assay to gain insight into C. elegans immunity
利用新型液体杀灭测定来深入了解秀丽隐杆线虫的免疫力
- 批准号:
8600650 - 财政年份:2012
- 资助金额:
$ 10.8万 - 项目类别:
Utilizing a novel liquid-killing assay to gain insight into C. elegans immunity
利用新型液体杀灭测定来深入了解秀丽隐杆线虫的免疫力
- 批准号:
8423249 - 财政年份:2012
- 资助金额:
$ 10.8万 - 项目类别:
相似国自然基金
基于“成分-肠道菌群-胆汁酸轴”研究生姜-干姜走守并用治疗抗生素相关性腹泻配伍机理
- 批准号:82374053
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗生素治疗压力下养殖场废弃物中抗生素抗性基因水平转移机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗生素治疗药物监测及耐药症候一体化阵列传感技术研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
具有内源抗炎活性的聚乙二醇化氨基糖苷类抗生素在脓毒症治疗中的应用研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
具有内源抗炎活性的聚乙二醇化氨基糖苷类抗生素在脓毒症治疗中的应用研究
- 批准号:32101073
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
噻唑啉-吡啶酮化合物作为结核病新药
- 批准号:
10698829 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Clostridioides difficile nucleobase scavenging in the competitive gut environment
竞争性肠道环境中艰难梭菌核碱基清除
- 批准号:
10677923 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
A Refined Murine Model of Post-sepsis Cognitive Impairment for Investigating Mitochondrial Abnormalities and Human ApoE4 Gene Polymorphisms
用于研究线粒体异常和人类 ApoE4 基因多态性的精制脓毒症后认知障碍小鼠模型
- 批准号:
10646579 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Intestinal Microbiota Affect Stroke Outcome by Modulating the Dendritic Cell-regulatory T Cell Axis
肠道微生物群通过调节树突状细胞调节 T 细胞轴影响中风结果
- 批准号:
10751249 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Development of a model of Gonococcal conjunctivitis for vaccine evaluations
开发用于疫苗评估的淋菌性结膜炎模型
- 批准号:
10740430 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别: